FDA-Inspected Site

Sanofi-Aventis Deutschland GmbH

10 FDA inspections are on record for Sanofi-Aventis Deutschland GmbH in Frankfurt Am Main, Germany.

483· Form 483 issued

Frankfurt Am Main, Germany · Last updated July 9, 2026

Overview

  • 10 FDA inspections are on record.
  • 7 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-01-16.

At a glance

Inspections

10

Form 483s

7

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
8 Jan 2025 – 16 Jan 2025Human Drugs483On file
6 May 2019 – 14 May 2019Human Drugs483On file
23 Feb 2017 – 3 Mar 2017Human Drugs483View 483 →
9 May 2016 – 13 May 2016Human DrugsClean
7 Dec 2015 – 10 Dec 2015Medical Devices & Rad Health483View 483 →
18 Jun 2015 – 26 Jun 2015Human Drugs483On file
2 Dec 2013 – 5 Dec 2013Human DrugsClean
24 Jun 2013 – 2 Jul 2013Human Drugs483On file
30 Apr 2012Not recordedClean
14 Jul 2011Not recorded483On file

Observations on record

Form 483 observations cited at this site, most recent first.

3 Mar 2017
21 CFR 211.113(b)

Validation lacking for sterile drug products

Cited by Junho Pak

3 Mar 2017
21 CFR 211.192

Written record of investigation incomplete

Cited by Junho Pak

3 Mar 2017
21 CFR 211.42(c)(10)(vi)

Equipment to control conditions

Cited by Junho Pak

3 Mar 2017
21 CFR 211.84(d)(2)

Establish reliability of supplier's C of A

Cited by Junho Pak

10 Dec 2015
21 CFR 820.20(c)

Management review - defined interval, sufficient frequency

Cited by Karl D Hezel

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(vi)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x
21 CFR 820.20(c)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Sanofi-Aventis Deutschland GmbH's 7 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat